# Comparison of Glycemic Control Achieved With 2 Different Needles

> **NCT00572052** · PHASE4 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 62 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Delivery Systems

## Interventions

- **DEVICE:** NovoFine® needle 6 mm
- **DEVICE:** Ultra-Fine needle 12.7 mm

## Key facts

- **NCT ID:** NCT00572052
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2003-10
- **Final completion:** 2003-10
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2017-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00572052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00572052, "Comparison of Glycemic Control Achieved With 2 Different Needles". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00572052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*